Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07011420 · ClinicalTrials.gov registry record · NA

Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control

A NA study of Amputation and Prosthesis User, sponsored by Liberating Technologies.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
2
Study locations

NCT07011420 is a NA study of Amputation and Prosthesis User that is actively recruiting participants, run by Liberating Technologies. The registered enrollment target is 32 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07011420, a NA study of Amputation and Prosthesis User, is actively recruiting participants, sponsored by Liberating Technologies.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to systematically evaluate whether or not two commonly held fundamental assumptions for pattern recognition control translates to functional performance when tested on individuals aged 18 years or older with upper limb absence at the transradial level while wearing a physical prosthesis. The specific aims of this study are: 1. To evaluate the effect of changing untargeted myoelectric channel count on the functional performance of transradial prosthesis users wearing a fully functional prosthesis via functional outcomes measures such as the Box and Blocks test. 2. To evaluate the effect of changing myoelectric channel targeting of a fixed number of myoelectric channels on the functional performance of transradial prosthesis users wearing a fully functional prosthesis via functional outcomes measures such as the Box and Blocks test. Researchers will perform a randomized crossover study to compare system configurations with different number of sensor channels and with various strategies for sensor placement on the limb. Participants will be assigned to a random test sequence that includes the following four different EMG channel conditions: Condition A: 4 untargeted channels Condition B: 8 untargeted channels Condition C: Up to 16 untargeted channels Condition D: 8 targeted channels Researchers will evaluate the effects of changing myoelectric channel counts on the functional prosthesis performance of individuals with transradial limb loss via functional outcome measures. Participants will: * Attend up to 5 in-lab sessions that are expected to last 4 hours. * Conduct site visits every 1-2 weeks to complete functional and self reported outcome measures with each condition. * Play virtual games with the Coapt Cuff for 15 minutes a day, 3 days a week in between visits.

Interventions

  • DEVICE Experimental socket with 4 untargeted channels active
  • DEVICE Experimental socket with 8 untargeted channels active
  • DEVICE Experimental socket with up to 16 untargeted channels active
  • DEVICE Experimental socket with 8 targeted channels active
  • DEVICE Coapt EMG Cuff

Study Locations (2)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Massachusetts

  • Liberating Technologies, Inc. - Holliston

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2025-10
Est. Completion 2026-06
Phase NA

Sponsor

Liberating Technologies

13 total trials

What the Registry Record Tells You About NCT07011420

The ClinicalTrials.gov registry entry for NCT07011420 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (76% lower). The listed sponsor is Liberating Technologies, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Amputation appearing as the primary indexed condition, and to 5 interventions - of which Experimental socket with 4 untargeted channels active is the first listed.

NCT07011420 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07011420 about?

NCT07011420 is a clinical study titled "Effects of Myoelectric Channel Count and Targeting for Upper Limb Prosthetic Control". The goal of this clinical trial is to systematically evaluate whether or not two commonly held fundamental assumptions for pattern recognition control translates to functional performance when tested on individuals aged 18 years or older with upper limb absence at the transradial level while wearing...

What is the current status of trial NCT07011420?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-10. Estimated completion is 2026-06.

What conditions does trial NCT07011420 study?

This clinical trial studies the following conditions: Amputation, Prosthesis User, Amputation, Traumatic, Upper Limb Amputation Below Elbow (Injury), Amputation, Congenital.

What interventions are being tested in trial NCT07011420?

The interventions under investigation include: Experimental socket with 4 untargeted channels active (DEVICE), Experimental socket with 8 untargeted channels active (DEVICE), Experimental socket with up to 16 untargeted channels active (DEVICE), Experimental socket with 8 targeted channels active (DEVICE), Coapt EMG Cuff (DEVICE).

Who is sponsoring clinical trial NCT07011420?

This trial is sponsored by Liberating Technologies, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07011420 being conducted?

This trial has 2 study locations across Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.